PMG Research of Winston-Salem was recently featured in the Business Briefcase in the Winston-Salem Journal, as well as on the WFMY News website. Our Winston-Salem and Wilmington offices are the first medical centers to start a study on Apnex Medical's Hypoglossal Nerve Stimulation (HGNS) system, which is an implantable device to treat obstructive sleep apnea (OSA).
The HGNS system provides a novel approach to treating OSA. The implanted medical device activates muscles of the upper airway to ensure that the airway remains open during sleep. The system monitors breathing during sleep and delivers mild stimulation to the hypoglossal nerve, which controls the tongue. As the nerve is stimulated, the tongue gently moves forward to keep the airway open.
In the United States, symptomatic OSA affects 1 in 4 men and 1 in 9 women. Worldwide, approximately 100 millon people have OSA.
For more information about this trial please visit http://www.sleepapneatrial.com/ or call 1-888-975-3370.